Work

Phase II trial of temsirolimus (CCI-779) in patients with relapsed or refractory multiple myeloma (MM): Preliminary results

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.7616

Authors: S. S. Farag, S. Zhang, M. Miller, M. Buckner, E. Kraut, K. Chan, C. Eng, J. C. Byrd, J. E. Dancey, M. R. Grever

Institutions: National Institutes of Health, The Ohio State University, Case Western Reserve University

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2294907521

Cites:

Cited by: 10

Related to: 10